產(chǎn)品基本信息
產(chǎn)品編號：E945420
產(chǎn)品名稱：Everolimus Retroaldol Degradation Product
產(chǎn)品CAS：1708118-13-1
規(guī)格含量：10mg
產(chǎn)品價格：面議
聯(lián)系我們:
產(chǎn)品詳細介紹
標準品編號:
E945420
名稱:
Everolimus Retroaldol Degradation Product
別名:
(S)-(2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-Hydroxyethoxy)-3-methoxycyclohexyl)-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl 1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trien-1-yl)-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylate; Everolimus Ring-opening Impurity
雜質(zhì):
Everolimus Impurity
CAS號:
1708118-13-1
分子式:
C??H??NO??
外觀:
白色至白色固體
熔點:
45-50°C
分子量:
958.22
儲存:
Amber Vial, -86°C Freezer, Under inert atmosphere
溶解度:
Chloroform (Slightly), Methanol (Slightly)
穩(wěn)定性:
Light and temperature Sensitive
種類:
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應用:
Everolimus Retroaldol Degradation Product is an impurity of Everolimus (E945400). Everolimus is a derivative of Rapamycin. Everolimus inhibits cytokine-mediated lymphocyte proliferation. Everolimus Impurity D
參考文獻
Dumont, F.J., et al.: Curr. Opin. Invest. Drugs, 2, 1220 (2001), Kovarik, J. M., et al.: Clin. Pharmacol. Ther., 69, 48 (2001), Nashan, B., et al.: Ther. Drug Monit., 24, 53 (2002),
?您的位置：
